Denmark· DK-28106135518
Gentamicin "Panpharma"
A gentamicin product containing gentamicinsulfat, registered in Denmark by Panpharma. The same ATC class is registered in 15 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Gentamicin is registered in 15 of 19 countries.
Countries holding a registration under ATC J01GB03 (gentamicin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Gentamicin · ATC J01GB03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of gentamicin costs, country by country.
Normalised to the WHO defined daily dose (0.24 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Gentamicin · price per daily dose (0.24 g)
USD · FX 28 Sept 2026
- CH Switzerland$578.87
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- GENTAMICINSULFAT
- Manufacturer
- Panpharma
- Country
- Denmark (DK)
- ATC code
- J01GB03
- ATC class
- Gentamicin
- Defined daily dose
- 0.24 g, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106135518
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
338 interactions on record for gentamicin.
Graded by severity as the source publishes them — 51 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gentamicin · interactions on record
338 records
- 51 severe
- 126 moderate
- 4 minor
- 157 info
Most severe, free to view
- Magnesium sulfateA06AD04severe
- MannitolA06AD16severe
- Polymyxin BA07AA05severe
- Magnesium sulfateA12CC02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01GB03
Gentamicin, as other registers publish it.
- United KingdomCidomycin 80mg/2ml solution for injection ampoulesAdvanz Pharma
- United KingdomCidomycin 80mg/2ml solution for injection vialsAdvanz Pharma
- United KingdomCidomycin Intrathecal 5mg/1ml solution for injection ampoulesAventis Pharma
- United KingdomCidomycin Paediatric 20mg/2ml solution for injection vialsBeacon Pharmaceuticals Ltd
- BelgiumDuracoll 130 mgSERB
- BelgiumDuracoll 32.5 mgSERB
- FinlandG-MycinOrion Corporation Orion Pharma
- FinlandG-MycinNEOFARMA
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/97b8e547-24c2-4026-b70b-3ebaef6e4ca7 GET /v1/drugs/97b8e547-24c2-4026-b70b-3ebaef6e4ca7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektions-/infusionsvæske, opløsning",
"source": "dkma",
"strength": "40 mg/ml",
"auth_role": "RMS",
"dk_drugid": "28106135518",
"substance": "GENTAMICINSULFAT",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": true,
"registration_date_serial": "43788"
}See everything about gentamicin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.